(1 - 10 von 12
)
EMA Grants Orphan Drug Designation to Debiopharm International SA's...
www.informazione.it
Orphan Drug Designation by the EMA provides regulatory and financial incentives to develop therapies for life-threatening or chronically debilitating…
FAR Newsletter- January/February Floral Association ...
www.floralassociationrockies.org
— Peggy Lipp, Windsor Hunter Margolf, Boulder Franklin Mera, Denver Jerrica Park, Boulder Peggy Roth, Parker Randy Strakhoen, Montrose › ...
FDA Grants Orphan Drug Designation to Debiopharm International SA's...
www.wallstreet-online.de
is an important regulatory milestone", stated Peggy Lipp, Director, Regulatory Affairs, Business Intelligence & Market Access, Debiopharm
FAR Newsletter- December 2009
www.floralassociationrockies.org
Mary Ann Blood, Brighton Robin Fischer, Denver Denise Fuller, Castle Rock Carmenn Lia, Arvada Peggy Lipp, Windsor Hunter Margolf, Boulder Franklin Mera ...
The ASCO Post
ascopost.com
... specific FGFR gene alteration who have few or no other treatment options,” said Peggy Lipp, Director, Regulatory Affairs, Market Intelligence ...
EMA Grants Orphan Drug Designation to Debio | Pharmasources.com
www.pharmasources.com
· "Obtaining orphan designation for Debio in the European Union is an important regulatory milestone", stated Peggy Lipp, Director, ...
News for Medical Independent Sales Representatives and Medical...
salesandmarketingnetwork.com
Healthcare Sales & Marketing Network: FDA Grants Orphan Drug Designation to Debiopharm International SA's IAP Inhibitor Debio in the Treatment of Ovarian...
Debiopharm's IAP inhibitor Debio to treat ovarian cancer gets US...
www.pharmabiz.com
Debiopharm's IAP inhibitor Debio to treat ovarian cancer gets US FDA orphan drug status
FDA grants fast track designation to Debio for FGFR
www.healio.com
— Peggy Lipp, director of regulatory affairs, market intelligence and market access at Debiopharm International, said in a company-issued ... › online
sortiert nach Relevanz / Datum